α‐glucosidase inhibition and the <i>in vivo</i> hypoglycemic effect of butyl‐isobutyl‐phthalate derived from the <i>Laminaria japonica</i> rhizoid

Abstract

The rhizoid of Laminaria japonica is widely used in Chinese medicine as a treatment for diabetes. Therefore, a bioactivity-tailored isolation and detailed chemical characterization was used to identify the antidiabetes compounds found in the L. japonica rhizoid. Liquid chromatography/mass spectrometry (LC/MS), proton NMR and carbon NMR spectra analyses demonstrated that the active compound was butyl-isobutyl-phthalate (BIP). BIP demonstrated a significant concentration-dependent, non-competitive inhibitory activity against α-glucosidase in vitro, with an IC(50) of 38 μm. In vivo, the ethyl acetate fraction (EAF) and purified BIP displayed a significant hypoglycemic effect in streptozocin-induced diabetic mice. The present study indicates BIP could be considered as an α-glucosidase inhibitor and developed as an important antidiabetes agent for type II diabetes therapy.